LONDON: Sativa Investments PLC, the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory diseases.
The research will be led by Professor Clive Page OBE PhD Professor of Pharmacology at King’s College London. Professor Page is a world authority on the pharmacology of inflammation and respiratory disease, having published over 250 scientific papers. He is a Fellow of the Royal Society of Biology and the British Pharmacological Society, and was awarded an OBE in 2017 for his “Services to Pharmacology.”
Sativa, which has a medicinal cannabis grower’s licence in process through the Home Office Drugs Licensing and Compliance Unit, will, subject to regulatory consent, supply the university, to order, with specific strains of cannabis plants that contain various combinations of the spectrum of at least 113 known cannabinoids.
The Company is able to provide this service through a combination of its commercial agreement with investee business Canada-based Veritas Pharma Inc., which specialises in identifying the optimum cultivation of various strains, and Sativa’s own on-site and highly successful testing facility, PhytoVista Laboratories, that has already undertaken over 1,000 forensic tests relating to a wide variety of cannabinoids, and is accredited and recommended by the UK’s Cannabis Trades Association (CTA).
Geremy Thomas, founder and Chief Executive Officer of Sativa Investments, said: “With the UK catching up fast in terms of recognising the benefits of medicinal cannabis, in-country research from the globally-recognised King’s College London will assist the medical profession, Government and Regulators in their deliberations.
“As the UK’s first medicinal cannabis investment vehicle, Sativa remains at the forefront of this fast-developing sector, which effectively mirrors what has been happening in North America since medicinal cannabis was first legalised in Canada in 2001, more than 17 years ago.”[the_ad id=”31605”]